International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banif working classification of kidney transplant pathology. A group of renal pathologists, nephrologists, and transplant surgeons met in Banif, Canada on August 2-4, 1991 to develop a schema for international standardization of nomenclature and criteria for the histologic diagnosis of renal allogralt rejection. Development continued after the meeting and the schema was validated by the circulation of sets of slides for scoring by participant pathologists. In this schema intimal arteritis and tubulitis are the principal lesions indicative of acute rejection. Glomerular, interstitial, tubular, and vascular lesions of acute rejection and "chronic rejection" are defined and scored 0 to 3+, to produce an acute and/or chronic numerical coding for each biopsy. Arteriolar hyalinosis (an indication of cyclosporine toxicity) is also scored. Principal diagnostic categories, which can be used with or without the quantitative coding, are: (1) normal, (2) hyperacute rejection, (3) borderline changes, (4) acute rejection (grade Ito III), (5) chronic allograft nephropathy ("chronic rejection") (grade Ito III), and (6) other. The goal is to devise a schema in which a given biopsy grading would imply a prognosis for a therapeutic response or long-term function. While the clinical implications must be proven through further studies, the development of a standardized schema is a critical first step. This standardized classification should promote international uniformity in reporting of renal allograft pathology, facilitate the performance of multicenter trials of new therapies in renal transplantation, and ultimately lead to improvement in the management and care of renal transplant recipients.
In the Banif schema tubulitis and intimal arteritis are regarded as the principal lesions indicative of acute rejection. Although the most obvious lesion in cases of renal transplant rejection is often interstitial infiltration by mononuclear inflammatory cells, five different studies in which stable kidney transplants were biopsied have shown that focal or mild diffuse infiltrates occur commonly in well functioning grafts [4] [5] [6] [7] [8] . The presence of interstitial infiltration has a negligible effect on graft survival [9] [10] [11] [12] . The index patient with a biopsy heavily infiltrated by lymphocytes illustrated in the 1984 study of Burdick et al [6] still has normal graft function ten years later and has never had a clinical rejection episode. D'Ardenne et al [4] found interstitial infiltration in 80% of stable grafts on cyclosporine therapy with diffuse infiltrates in 42%. Clearly, if interstitial infiltration is seen in a significant proportion of well functioning grafts, it cannot be used alone as a specific sign of rejection. It is only when interstitial inflammation is accompanied by tubular invasion (tubulitis) that it has any degree of specificity. Although it is not specific for rejection, interstitial inflammation is a typical finding in that condition, and various authors have suggested grading severity of rejection by the extent of the interstitial infiltrate. The objection to use of severity of interstitial inflammation seen on biopsy to grade rejection relates to sampling error. Rejection in the kidney, as in the heart [1], begins as a patchy process. By analogy with animal models, if one examined a cross section of the entire kidney it is likely that there would be a good correlation between extent and intensity of inflammation and severity of rejection [13] . However random without rejection as mentioned above. Also rare cases of moderate-to-severe rejection may be sampled in such a way that an entire biopsy core may appear normal ( Fig. la and b) . The degree of inifitration has no correlation with response to therapy [5, 11, 121 , probably due, at least in part, to sampling error.
Methods
Description of the schema sampling by a single core needle biopsy may eliminate this
The formal classification is presented in Tables 1 to 4 . It correlation and interstitial infiltrates can be seen in patients includes hyperacute rejection, borderline changes, three grades Severe interstitial fibrosis and tubular atrophy and tubular loss 6. Other (changes not considered to be due to rejection, see Table 3) The recommended format of report is a descriptive narrative signout followed by numerical codes in parentheses (see Table 2 ). Categorization should in the first instance be based solely on pathologic changes, then integrated with clinical data as a second step. More than one diagnostic category may be used if appropriate. 2) as a defining feature, since its significance as evidence of rejection is uncertain although its presence in the first few months post-transplant has been reported to shorten graft survival time [14] [15] [16] [17] [18] [19] [20] . Glomerulitis as described in Table 4 is included in the scoring system for individual pathologic features, however (see below). The classification also groups together under the term "chronic allograft nephropathy" at least four entities that at present cannot always be distinguished by biopsy (chronic rejection, chronic cyclosporine toxicity, hypertensive vascular disease, and chronic infection and/or reflux). New-onset fibrous intimal thickening (Fig. 3 ) is suggestive of chronic rejection [21] if recipient hypertension can be excluded as a cause.
In comparison with the summary classification of diagnostic categories and grades, which may undergo evolutionary changes, the numerical scoring system (Table 2) is less likely to be altered with time. The scoring codes which are used to establish rejection grades but also have independent usefulness are designated g, i, t, v, ah, for glomerular, interstitial, tubular, or vascular changes, and arteriolar hyalinosis, respectively, in the acute setting. Chronic changes are scored cg, ci, ct and cv, respectively. It would be possible to apply relative weightings and calculate overall severity scores using this coding system.
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The Banff class jfication of kidney transplant pathology 6. 7. 8. Arteritis, transmural. Injury and inflammation of the whole arterial wall including the media, necrosis of medial smooth muscle cells, fibrin insudation and cellular infiltration with mononuclear as well as polymorphonuclear leukocytes.
Borderline changes. Changes which might be considered suggestive of rejection but which are nondiagnostic (such as a moderate interstitial mononuclear cell infiltrate with very mild tubulitis).
De novo glomerulonephritis. Glomerulonephritis in the allograft morphologically dissimilar to the original disease and distinct from transplant glomerulopathy or transplant glomerulitis. Presumed to be due to etiologies similar to those responsible for native kidney glomerulonephritis.
Hyperacute rejection. Rejection presumed to be due to preformed antibody, usually characterized by polymorph accumulation in glomerular and peritubular capillaries at one hour post-transplant with subsequent endothelial damage and capillary thrombosis.
Ischemic glomerulopathy. A. Acute: glomerular capillary engorgement and glomerular necrosis. May occur in hyperacute and in severe acute rejection. B. Late: Thickening, wrinkling and collapse of glomerular capillary walls associated with extracapillary fibrotic material. May be a sequel to diffuse arterial occlusion in chronic vascular rejection.
Recurrence. Lesions in the graft morphologically similar to the original disease, and presumed to be due to persistence of pathogenetic mechanism leading to end stage disease in the native kidney, such as, diabetic glomerulopathy, recurrent glomerulonephritis, and amyloidosis.
Transmission. Persistence of lesions which were present in the transplanted kidney before transplantation, such as, glomerulonephritis. This should not be mistaken for recurrence.
Transplant glomerulopathy. Immunologic glomerular damage due to transplant antigens. A. Early form (glomerulitis): Endocapillary accumulation of lymphocytes and monocytes with endothelial cell swelling. B. Late form (syn. chronic transplant glomerulopathy): Mesangial cell proliferation, peripheral mesangial interposition and sometimes cellular crescents. The late form is usually associated with marked proteinuria, often in the nephrotic range. Should be distinguished from ischemic glomerular change, recurrent glomerulonephritis and transmitted glomerulonephritis.
Tubulitis. Infiltration of tubular epithelium by leukocytes, usually lymphocytes.
The scoring codes can also be used without the classification system or vice versa if that is the wish of individual centers.
The classification in Table 1 combined with the differential diagnoses ("other" categories) in Table 3 and the definitions in  Table 4 will provide a reproducible system which maximizes the clinical utility of the biopsy. The utilization of this schema in studies of therapeutic modalities to minimize rejection will be an important assessment of its validity. The schema is designed so that the false positive rate in diagnosis of rejection should be very low. Standards for adequacy and minimum sampling and stains are provided in Table 2 . If these standards are not followed severity of lesions may be underestimated. Owing to the patchiness of early rejection there may be a substantial false negative rate if only a single core of tissue containing a small amount of cortex is examined. This diminishes considerably if two or three cores are obtained or if there is a substantial amount of cortex represented in a single large core.
The portion of the schema which evaluates new-onset arteriolar hyaline thickening (Fig. 4) as a sign of cyclosporine nephrotoxicity assumes the presence of a baseline (implantation) biopsy or other prior negative biopsy for comparison.
Although on occasion a destructive hyalinosis characteristic of cyclosporine toxicity may be recognized [22] , arteriolar hyaline thickening is usually of little diagnostic value in the absence of a prior biopsy lacking this change, as it could have been present in the donor kidney as a result of hypertension or age. This change, which is potentially reversible [23] , may also develop independent of cyclosporine toxicity as a consequence of diabetes or hypertension in the recipient. Similarly, some chronic changes, such as fibrous intimal thickening and interstitial fibrosis may pre-exist in kidneys from older donors [241.
The concepts of "acute" and "chronic" entities in the transplanted kidney may require further modification in the future.
Neither the lesions observed themselves nor the time posttransplant are sufficient to completely define these terms. Acute rejection may occur many years after transplantation if immunosuppression is stopped. Similarly, "chronic" lesions may be observed in an implantation or early post-transplant biopsy if the donor has age-related vascular disease. Such lesions are a definite indication of chronic processes in the recipient only if they were not present in the donor. Despite the fact that there will be individual variations in therapeutic approach, it is necessary to have a general understanding of the defining characteristics and significance of the three grades of acute rejection.
Grade I (mild) acute rejection differs from the borderline changes category in that it has tubulitis quantitatively more severe than that observed in kidneys with normal function or in ATN [511. Tubulitis severity is most easily assessed in PASstained sections by examining the number of lymphocytes present in the most inflamed tubule in an area after observing the overall severity of interstitial inflammation and degree of tubulitis in less affected tubules. The use of thin well stained sections is a necessary prerequisite for this assessment to be reliable. Quantitative criteria for tubulitis scoring are discussed further in the section below.
In Grade II (moderate) rejection the diagnosis of rejection is more secure because the lesions on which the diagnosis depends, foci of tubulitis with >10 lymphocytes per most inflamed tubular cross section (Fig. 5) or intimal arteritis (Fig. 6) , are highly specific for rejection. Cases with this grade of rejection are likely to behave more aggressively than those in Grade I. In Grade III (severe) rejection the process is so aggressive that highly potent antirejection therapies need to be considered, as well as the possibility that the rejection process may not be reversible. Necrotizing vascular changes (Fig. 6C ) suggest irreversible rejection, and are most commonly observed only in nephrectomy specimens.
Quantitative criteria for lesion severity Preliminary results assessing panel slides with the use of the Banff schema indicate an 82% agreement on diagnosis of rejection [25] . The panel slide assessments, which will be reported separately, led to the development of quantitative criteria for lesion severity (Tables 6 to 10 ). These criteria represent a compromise between a formal morphometric assessment of these lesions and a fully qualitative approach. Our experience with the panel slides also resulted in the recommendation that PAS stains be used to assess tubulitis, glomerulitis, and arteriolar hyaline thickening.
In the tubulitis scoring (Table 6) it is important to differentiate lymphocytes from apoptotic tubular cells (Fig. 7) . 'It '3
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The detailed version of the Banif Schema outlined in Tables 1 to 4 and described in the text is designed to address all circumstances that might be encountered. However, the simplified schema above will suffice for many common biopsy appearances.
rejection. The interstitial inflammation scoring (Table 7) evaluDiscussion ates extent of parenchymal infiltration rather than intensity (which is to some extent indirectly evaluated in the tubulitis Unlike the heart transplant formulation [1, 26] , the schema scoring),
for the kidney employs the term "rejection" only for those Table 6 . Quantitative criteria for tubulitis ("t") score (Q-3+) (assumes that minimum sampling standards in Table 2 sion. Thus "grade 1 rejection" in the heart schema, which would not be treated, would correspond to the "borderiine changes" category in the Banif formulation. Clearly, the differentiation of borderline changes from mild rejection is a crucial part of the Banff schema, since it may mean the difference between not treating and treating an episode of reduced renal In most centers patients will not be treated for rejection unless they have clinical signs (allograft dysfunction) suggesting this diagnosis, regardless of the biopsy findings observed.
Patients with persisting allograft failure from time of transplantation (delayed graft function) will, however, have to be diagnosed and treated largely on the basis of biopsy appearance, since the allograft dysfunction observed clinically could be due to acute tubular necrosis, acute rejection, cyclosporine nephrotoxicity, or a combination of these. Rejection has more reliable clinical signs in the kidney once allograft function commences than it does in the heart. In this setting changes in renal function are a relatively sensitive indicator of kidney allograft rejection, whereas changes in cardiac function occur only in late stages of heart allograft rejection. For this reason it may not be reasonable to make a diagnosis of rejection in the functioning kidney transplant solely on histologic grounds, whereas biopsy evidence alone must frequently be used in the heart and other functioning solid organ transplants in which rejection is often clinically silent. Reports in the heart of persistent histologic evidence of rejection without evidence of graft dysfunction [381 underscore the great advantage of working with an organ like the kidney in which both functional and structural data can be used together in many instances to make a secure diagnosis of rejection. On the other hand, elevation of serum creatinine may prove to be too insensitive an indicator of rejection. Future studies may show that prolongation of graft survival results if the "subclinical" rejection represented by the borderline changes category in the present classification is treated with increased immunosuppression.
The Banif schema is based on the concept that the degree of lymphocytic invasion of tubules (tubulitis) is a better measure of severity of rejection than the intensity or extent of interstitial lymphocytic infiltration (Introduction). Tubulitis is a typical feature of acute rejection [39] [40] [41] . Analysis of protocol biopsies from patients with stable function or acute tubular necrosis [5] shows that very mild tubulitis may occur in these settings (up to Most biopsies contain only two or three arterial cross sections so it is easy for all observers to concentrate on exactly the same fields in their assessment of intimal arteritis in an individual case. In contrast a single biopsy section may contain several hundred tubular cross sections. If the biopsy is diffusely infiltrated it becomes a matter of chance whether two observers concentrate on the same microscopic fields in assessment of tubulitis. Devising a more accurate and reproducible method for assessing tubulitis which is still practical and time-efficient remains one of our goals for the future.
An interstitial infiltrate of polymorphonuclear leukocytes as a feature of acute rejection has not been dealt with specifically in the present schema. Polymorphs and eosinophils are sometimes present in the interstitial infiltrate of acute rejection. Pure polymorph infiltrates occur at the periphery of recent infarcts and may therefore be seen in cases with arteritis and infarction.
They may also be observed in cases of antibody-mediated rejection [47, 48] and are particularly likely to be seen in ABO-incompatible grafts.
Concerns about inaccuracy due to sampling error led Rapaport, Converse and Billingham to state in 1977 that "percutaneous renal biopsy of renal transplants has been generally abandoned because rejection injury is not distributed uniformly throughout the transplanted kidney" [49] . Although the demise of the renal allograft biopsy did not occur, the sampling error considerations noted by Rapaport are still important today. As Sanfilippo has emphasized, "healing in" of the graft may lead to a subcapsular infiltrate unrelated to rejection [50] . Substantial interstitial inifitrates may also be found in non-rejecting grafts in the mid-to-deep cortex [4] [5] [6] [7] [8] . Although experimental studies [51, 521 have indicated that serious sampling error with percutaneous biopsies is likely to be infrequent, such error nevertheless occurs and must be taken into account in biopsy interpretation.
In conclusion, we have presented a formulation for the evaluation of rejection and other conditions in renal allograft biopsies. We feel that it can be applied reliably to diagnose and grade rejection as long as criteria of minimum sampling and specimen adequacy are met. The schema presented is an important step in the design of effective multicenter trials and in the study of the clinical significance of lesions observed on biopsy. This classification has already been adopted for international multicenter trials of four new immunosuppressive agents (RS61443, Cyclosporin 0, brequinar, and anti-CD4S), and should lead to international uniformity in evaluation of biopsy findings in many centers currently performing renal transplantation. The numerical coding of specific biopsy features, in particular, should contribute in a major way to objective data assessment and statistical analysis. The ultimate hope is that such a classification will lead to major improvements in patient care and management.
